Qube Research & Technologies (QRT)’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-127,985
Closed -$4.16M – 3776
2025
Q4
$4.16M Buy
+127,985
New +$5.48M ﹤0.01% 1869
2025
Q2
– Sell
-723,767
Closed -$21.4M – 3715
2025
Q1
$21.4M Sell
723,767
-1,140,999
-61% -$42.4M 0.02% 720
2024
Q4
$45.1M Sell
1,864,766
-464,793
-20% -$11.5M 0.06% 410
2024
Q3
$42.9M Buy
2,329,559
+651,077
+39% +$11.7M 0.06% 388
2024
Q2
$33.9M Buy
1,678,482
+1,518,707
+951% +$25.3M 0.05% 417
2024
Q1
$2.47M Buy
+159,775
New +$1.8M ﹤0.01% 1634
2023
Q4
– Sell
-264,266
Closed -$1.66M – 4500
2023
Q3
$1.66M Buy
+264,266
New +$1.97M ﹤0.01% 1475
2022
Q2
– Sell
-19,754
Closed -$105K – 2765
2022
Q1
$105K Sell
19,754
-16,376
-45% -$81K ﹤0.01% 2065
2021
Q4
$237K Buy
+36,130
New +$261K ﹤0.01% 1901
2021
Q1
– Sell
-11,168
Closed -$163K – 2125
2020
Q4
$163K Buy
+11,168
New +$124K ﹤0.01% 1567

Other funds holding HIMS

Qube Research & Technologies (QRT)'s HIMS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 127,985 shares — an estimated $4.16M sold.

Qube Research & Technologies (QRT) first reported a position in HIMS in Q4 2020 and held it in 10 quarters. The position peaked at $45.1M in Q4 2024. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 127,985 Hims & Hers Health shares in Q1 2026, an estimated $4.16M.
  • Qube Research & Technologies (QRT) first reported a position in Hims & Hers Health in Q4 2020 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Hims & Hers Health position peaked at $45.1M in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.